Results 261 to 270 of about 31,062 (287)

Beta‐blockers in patients with heart failure with reduced ejection fraction and concomitant chronic obstructive pulmonary disease: Cardiovascular and respiratory outcomes

open access: yesEuropean Journal of Heart Failure, EarlyView.
In total, 5084 patients from Swedish registries with both heart failure (HF) with reduced ejection fraction (HFrEF) and chronic obstructive pulmonary disease (COPD) were included. Confounding was handled by overlap weighting based on propensity scores for beta‐blocker use. Patients were followed up for 5 years, or until death, emigration from Sweden or
Benedikt N. Beer   +17 more
wiley   +1 more source

Heart failure and chronic obstructive pulmonary disease. A combination not to be underestimated. [PDF]

open access: yesHeart Fail Rev
Magrì D   +10 more
europepmc   +1 more source

Association between antecedent myocardial infarction and heart failure with preserved versus reduced ejection fraction

open access: yes
European Journal of Heart Failure, EarlyView.
Mohammad A. Almesned   +12 more
wiley   +1 more source

An individual treatment effect approach to predict response to mineralocorticoid receptor antagonists in patients with heart failure and reduced ejection fraction

open access: yesEuropean Journal of Heart Failure, EarlyView.
Aims Mineralocorticoid receptor antagonists (MRAs) are often underused in patients with heart failure (HF) and reduced ejection fraction (HFrEF). Individual treatment effect (ITE) may assist physicians in making timely decisions about which patients are the best suited for personalized therapy.
Masatake Kobayashi   +9 more
wiley   +1 more source

Effectiveness and safety of vericiguat in patients with heart failure and reduced ejection fraction: a narrative review of real-world evidence studies. [PDF]

open access: yesFront Cardiovasc Med
Escobar C   +8 more
europepmc   +1 more source

Liraglutide and weight loss among patients with advanced heart failure and a reduced ejection fraction: Insights from the FIGHT trial [PDF]

open access: yes, 2018
Ambrosy, Andrew P   +13 more
core   +1 more source

Global patterns of polypharmacy after acute heart failure hospitalization: Prevalence and outcomes from the REPORT‐HF registry

open access: yesEuropean Journal of Heart Failure, EarlyView.
Global patterns of polypharmacy after acute heart failure hospitalization. GDMT, guideline‐directed medical therapy; HF, heart failure. Aims Polypharmacy, defined as the concurrent use of ≥5 medications, is prevalent among older adults with heart failure (HF).
Wan Ting Tay   +19 more
wiley   +1 more source

Right atrial and right ventricular strain in patients with acute decompensated heart failure: a pilot study. [PDF]

open access: yesFront Cardiovasc Med
Jurica J   +7 more
europepmc   +1 more source

Home - About - Disclaimer - Privacy